펄스 바이오사이언시스(PLSE)는 NAS에 상장된 Healthcare · Medical Instruments & Supplies 기업입니다. 현재가 $53.87 (+6.44%), 시가총액 $1.82B.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc.
펄스 바이오사이언시스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
펄스 바이오사이언시스의 현재 주가는 $53.87 (+6.44%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
펄스 바이오사이언시스의 시가총액은 약 $1.82B입니다.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin…